168 related articles for article (PubMed ID: 12353143)
1. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
3. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
4. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
Kyo S; Inoue M
Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
6. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Keith WN; Bilsland A; Hardie M; Evans TR
Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer.
Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW
Breast Cancer Res Treat; 2006 Mar; 96(1):73-81. PubMed ID: 16319992
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
Philippi C; Loretz B; Schaefer UF; Lehr CM
J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Hiyama E; Kodama T; Shinbara K; Iwao T; Itoh M; Hiyama K; Shay JW; Matsuura Y; Yokoyama T
Cancer Res; 1997 Jan; 57(2):326-31. PubMed ID: 9000577
[TBL] [Abstract][Full Text] [Related]
11. Can inhibition of telomerase increase pancreatic cancer cell's susceptibility to chemotherapeutic reagents?
Teng LS; Fahey TJ
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):155-60. PubMed ID: 14607648
[TBL] [Abstract][Full Text] [Related]
12. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
15. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition, oligonucleotides, and clinical trials.
Corey DR
Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
18. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
19. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
[TBL] [Abstract][Full Text] [Related]
20. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase.
Sun B; Huang Q; Liu S; Chen M; Hawks CL; Wang L; Zhang C; Hornsby PJ
Cancer Res; 2004 Sep; 64(17):6144-51. PubMed ID: 15342398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
